Drug Development Novo Nordisk Legal Challenges Liquidia Corp Public Health Contracts Sanofi Regulatory Affairs Gene Therapy Developers Profit Margins Drug Manufacturers Vaccine Development Market Trends Financial Holdings Financial Compliance Acquisitions Supply Chain Pricing Strategies Fraudulent Practices Oncology Services Investment Strategies
Defendants deny allegations that they manipulated prescription reimbursements to extract more than €1.2 million from statutory health insurers.